Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.97 USD | +1.56% | +0.08% | +14.61% |
03-14 | Barrington Ups Price Target on Anika Therapeutics to $37 From $29, Keeps Outperform Rating | MT |
03-13 | Transcript : Anika Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.61% | 381M | |
-3.45% | 87.17B | |
+1.97% | 40.1B | |
+56.53% | 25.12B | |
-14.82% | 15.59B | |
-8.82% | 12B | |
-16.29% | 11.8B | |
-41.58% | 11.8B | |
+6.14% | 8.81B | |
-10.41% | 8.24B |
- Stock Market
- Equities
- ANIK Stock
- News Anika Therapeutics, Inc.
- Sector Update: Health Care